A detailed history of Swiss National Bank transactions in Liquidia Corp stock. As of the latest transaction made, Swiss National Bank holds 89,500 shares of LQDA stock, worth $993,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,500
Previous 97,200 7.92%
Holding current value
$993,450
Previous $1.17 Million 23.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$8.9 - $14.11 $68,530 - $108,647
-7,700 Reduced 7.92%
89,500 $895,000
Q2 2024

Aug 08, 2024

BUY
$11.96 - $15.71 $88,504 - $116,254
7,400 Added 8.24%
97,200 $1.17 Million
Q1 2024

May 07, 2024

BUY
$11.35 - $16.73 $1.02 Million - $1.5 Million
89,800 New
89,800 $1.32 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $714M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.